Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.

Realini N, Rubino T, Parolaro D.

Pharmacol Res. 2009 Aug;60(2):132-8. doi: 10.1016/j.phrs.2009.03.006. Epub 2009 Mar 17. Review.

PMID:
19559364
[PubMed - indexed for MEDLINE]
2.

Long lasting consequences of cannabis exposure in adolescence.

Rubino T, Parolaro D.

Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S108-13. doi: 10.1016/j.mce.2008.02.003. Epub 2008 Feb 13. Review.

PMID:
18358595
[PubMed - indexed for MEDLINE]
3.

Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.

Schneider M.

Addict Biol. 2008 Jun;13(2):253-63. doi: 10.1111/j.1369-1600.2008.00110.x. Review.

PMID:
18482434
[PubMed - indexed for MEDLINE]
4.

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Malone DT, Hill MN, Rubino T.

Br J Pharmacol. 2010 Jun;160(3):511-22. doi: 10.1111/j.1476-5381.2010.00721.x. Review.

PMID:
20590561
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.

Bossong MG, Niesink RJ.

Prog Neurobiol. 2010 Nov;92(3):370-85. doi: 10.1016/j.pneurobio.2010.06.010. Epub 2010 Jul 16. Review.

PMID:
20624444
[PubMed - indexed for MEDLINE]
6.

Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Jutras-Aswad D, DiNieri JA, Harkany T, Hurd YL.

Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):395-412. doi: 10.1007/s00406-009-0027-z. Epub 2009 Jul 2. Review.

PMID:
19568685
[PubMed - indexed for MEDLINE]
7.

Cannabis and psychiatric disorders: it is not only addiction.

Leweke FM, Koethe D.

Addict Biol. 2008 Jun;13(2):264-75. doi: 10.1111/j.1369-1600.2008.00106.x. Review.

PMID:
18482435
[PubMed - indexed for MEDLINE]
8.

Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model.

Adriani W, Laviola G.

Behav Pharmacol. 2004 Sep;15(5-6):341-52. Review.

PMID:
15343057
[PubMed - indexed for MEDLINE]
9.

Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.

Campolongo P, Trezza V, Palmery M, Trabace L, Cuomo V.

Int Rev Neurobiol. 2009;85:117-33. doi: 10.1016/S0074-7742(09)85009-5. Review.

PMID:
19607965
[PubMed - indexed for MEDLINE]
10.
11.

Cannabis and the developing brain: insights from behavior.

Trezza V, Cuomo V, Vanderschuren LJ.

Eur J Pharmacol. 2008 May 13;585(2-3):441-52. doi: 10.1016/j.ejphar.2008.01.058. Epub 2008 Mar 18. Review.

PMID:
18413273
[PubMed - indexed for MEDLINE]
12.

Adolescent exposure to cannabis as a risk factor for psychiatric disorders.

Rubino T, Zamberletti E, Parolaro D.

J Psychopharmacol. 2012 Jan;26(1):177-88. doi: 10.1177/0269881111405362. Epub 2011 Jul 18. Review.

PMID:
21768160
[PubMed - indexed for MEDLINE]
13.

Behavioural consequences of maternal exposure to natural cannabinoids in rats.

Navarro M, Rubio P, de Fonseca FR.

Psychopharmacology (Berl). 1995 Nov;122(1):1-14. Review.

PMID:
8711059
[PubMed - indexed for MEDLINE]
14.

Cannabis, cannabinoids and schizophrenia: integration of the evidence.

Cohen M, Solowij N, Carr V.

Aust N Z J Psychiatry. 2008 May;42(5):357-68. doi: 10.1080/00048670801961156. Review.

PMID:
18473254
[PubMed - indexed for MEDLINE]
15.

Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?

Di Forti M, Morrison PD, Butt A, Murray RM.

Curr Opin Psychiatry. 2007 May;20(3):228-34. Review.

PMID:
17415074
[PubMed - indexed for MEDLINE]
16.

Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents.

Campolongo P, Trezza V, Ratano P, Palmery M, Cuomo V.

Psychopharmacology (Berl). 2011 Mar;214(1):5-15. doi: 10.1007/s00213-010-1892-x. Epub 2010 Jun 17. Review.

PMID:
20556598
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Role of cannabis and endocannabinoids in the genesis of schizophrenia.

Fernandez-Espejo E, Viveros MP, Núñez L, Ellenbroek BA, Rodriguez de Fonseca F.

Psychopharmacology (Berl). 2009 Nov;206(4):531-49. doi: 10.1007/s00213-009-1612-6. Epub 2009 Jul 24. Review.

PMID:
19629449
[PubMed - indexed for MEDLINE]
18.

Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.

Spano MS, Fadda P, Fratta W, Fattore L.

Curr Drug Targets. 2010 Apr;11(4):450-61. Review.

PMID:
20017729
[PubMed - indexed for MEDLINE]
19.

Neurobiology of marijuana abuse.

Abood ME, Martin BR.

Trends Pharmacol Sci. 1992 May;13(5):201-6. Review.

PMID:
1604713
[PubMed - indexed for MEDLINE]
20.

Cannabis and neurodevelopment: implications for psychiatric disorders.

Sundram S.

Hum Psychopharmacol. 2006 Jun;21(4):245-54. Review.

PMID:
16783814
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk